Northwestern University

About: Northwestern University is a education organization based out in Evanston, Illinois, United States. It is known for research contribution in the topics: Population & Medicine. The organization has 75430 authors who have published 188857 publications receiving 9463252 citations. The organization is also known as: Northwestern & NU.

Whose Space? Differences Among Users and Non-Users of Social Network Sites

Abstract: Are there systematic differences between people who use social network sites and those who stay away, despite a familiarity with them? Based on data from a survey administered to a diverse group of young adults, this article looks at the predictors of SNS usage, with particular focus on Facebook, MySpace, Xanga, and Friendster. Findings suggest that use of such sites is not randomly distributed across a group of highly wired users. A person's gender, race and ethnicity, and parental educational background are all associated with use, but in most cases only when the aggregate concept of social network sites is disaggregated by service. Additionally, people with more experience and autonomy of use are more likely to be users of such sites. Unequal participation based on user background suggests that differential adoption of such services may be contributing to digital inequality.

Judgment of contingency in depressed and nondepressed students: sadder but wiser?

Abstract: SUMMARY How are humans' subjective judgments of contingencies related to objective contingencies? Work in social psychology and human contingency learning predicts that the greater the frequency of desired outcomes, the greater people's judgments of contingency will be. Second, the learned helplessness theory of depression provides both a strong and a weak prediction concerning the linkage between subjective and objective contingencies. According to the strong prediction, depressed individuals should underestimate the degree of contingency between their responses and outcomes relative to the objective degree of contingency. According to the weak prediction, depressed individuals merely should judge that there is a smaller degree of contingency between their responses and outcomes than nondepressed individuals should. In addition, the present investigation deduced a new strong prediction from the helplessness theory: Nondepressed individuals should overestimate the degree of contingency between their responses and outcomes relative to the objective degree of contingency. In the experiments, depressed and nondepressed students were presented with one of a series of problems varying in the actual degree of contingency. In each problem, subjects estimated the degree of contingency between their responses (pressing or not pressing a button) and an environmental outcome (onset of a green light). Performance on a behavioral task and estimates of the conditional probability of green light onset associated with the two response alternatives provided additional measures for assessing beliefs about contingencies. Depressed students' judgments of contingency were surprisingly accurate in all four experiments. Nondepressed students, on the other hand, overestimated the degree of contingency between their responses and outcomes when noncontingent outcomes were frequent and/or desired and underestimated the degree of contingency when contingent outcomes were undesired. Thus, predictions derived from social psychology concerning the linkage between subjective and objective contingencies were confirmed for nondepressed students but not for depressed students. Further, the predictions of helplessness theory received, at best, minimal support. The learned helplessness and self-serving motivational bias hypotheses are evaluated as explanations of the results. In addition, parallels are drawn between the present results and phenomena in cognitive psychology, social psychology, and animal learning. Finally, implications for cognitive illusions in normal people, appetitive helplessness, judgment of contingency between stimuli, and learning theory are discussed.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

Abstract: Background Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus remdesivir are not known. Methods We conducted a double-blind, randomized, placebo-controlled trial evaluating baricitinib plus remdesivir in hospitalized adults with Covid-19. All the patients received remdesivir (≤10 days) and either baricitinib (≤14 days) or placebo (control). The primary outcome was the time to recovery. The key secondary outcome was clinical status at day 15. Results A total of 1033 patients underwent randomization (with 515 assigned to combination treatment and 518 to control). Patients receiving baricitinib had a median time to recovery of 7 days (95% confidence interval [CI], 6 to 8), as compared with 8 days (95% CI, 7 to 9) with control (rate ratio for recovery, 1.16; 95% CI, 1.01 to 1.32; P = 0.03), and a 30% higher odds of improvement in clinical status at day 15 (odds ratio, 1.3; 95% CI, 1.0 to 1.6). Patients receiving high-flow oxygen or noninvasive ventilation at enrollment had a time to recovery of 10 days with combination treatment and 18 days with control (rate ratio for recovery, 1.51; 95% CI, 1.10 to 2.08). The 28-day mortality was 5.1% in the combination group and 7.8% in the control group (hazard ratio for death, 0.65; 95% CI, 0.39 to 1.09). Serious adverse events were less frequent in the combination group than in the control group (16.0% vs. 21.0%; difference, -5.0 percentage points; 95% CI, -9.8 to -0.3; P = 0.03), as were new infections (5.9% vs. 11.2%; difference, -5.3 percentage points; 95% CI, -8.7 to -1.9; P = 0.003). Conclusions Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT04401579.).

Self‐assembly of peptide amphiphiles: From molecules to nanostructures to biomaterials

Abstract: Peptide amphiphiles are a class of molecules that combine the structural features of amphiphilic surfactants with the functions of bioactive peptides and are known to assemble into a variety of nanostructures. A specific type of peptide amphiphiles are known to self-assemble into one-dimensional nanostructures under physiological conditions, predominantly nanofibers with a cylindrical geometry. The resultant nanostructures could be highly bioactive and are of great interest in many biomedical applications, including tissue engineering, regenerative medicine, and drug delivery. In this context, we highlight our strategies for using molecular self-assembly as a toolbox to produce peptide amphiphile nanostructures and materials and efforts to translate this technology into applications as therapeutics. We also review our recent progress in using these materials for treating spinal cord injury, inducing angiogenesis, and for hard tissue regeneration and replacement.